YTHDF1 mediates frizzled class receptor 5 (FZD5) expression to regulate the WNT/β-catenin axis to exert oncogenic function as a potential HCC therapeutic strategy (Liu et al., 2020e). The gene discussed is FZD5; the disease is hepatocellular carcinoma.